Full-Time

Pharmaceutical Technician

Posted on 11/23/2025

Mallinckrodt

Mallinckrodt

1,001-5,000 employees

Specialty pharmaceutical developer, manufacturer, distributor

No salary listed

Fenton, MO, USA

In Person

Category
Biology & Biotech (2)
,
Requirements
  • High School diploma or GED.
Responsibilities
  • Operates equipment required in the manufacture of pharmaceutical products including, sifters, blenders, tablet press, fluid bed, granulation, encapsulation, pan coaters and packaging.
  • Monitor the production process, make periodic checks and adjust equipment or work practices to maximize production efficiency, yields, quality and safety.
  • Accurately reports production and ensures reports are completed as required.
  • Prepares and submits samples to Quality Control Laboratory.
  • Reviews, writes and update SOPs.
  • Maintains control of DEA scheduled material in accordance with accepted policy, practice and procedure.
  • Perform basic maintenance, trouble shooting, minor repairs, machine setup and breakdown.
  • Perform inventory functions including but not limited to WIP, Cycle Counts, receiving/shipping functions, etc.
  • Follows all EHS rules and regulations.
  • Take proactive steps to ensure a safe work environment and ensure safety issues are corrected.
  • Complies with all site security requirements.
  • Performs lock-out/tag-out procedures according to SOPs.
  • Follows safe working practices in the execution of their assigned duties.
  • Maintains clean work area; clear away debris, damaged or defective product, cartons, labels and packaging supplies.
  • Ensures that processes comply with all cGMP regulations in regards to process and cleaning validations.
  • Participates in investigations and corrective actions
  • Participate and provide direction in process improvements, reviews corrective actions to provide input.
  • Troubleshoot equipment, processes and production problems with appropriate personnel.
  • Perform other duties as assigned.
Desired Qualifications
  • Solid oral dose production experience is preferred.
  • Excellent communication skills, both written and oral
  • Strong attention to details
  • Mechanical knowledge of production equipment
  • Ability to work in and promote a team environment.
  • Knowledge of cGMP regulations
  • Strong working knowledge of Microsoft Office products

Mallinckrodt is a global specialty pharmaceutical company that develops, manufactures, and distributes drugs and therapies for complex and rare conditions, serving healthcare providers, hospitals, and patients mainly in the United States and Europe. Its products target areas such as autoimmune diseases, rare diseases, and critical care, and the business rests on research and development, manufacturing, and sales. The company differentiates itself through a patient-centric approach, a commitment to integrity, ongoing innovation, and collaboration, grounded in more than 150 years of experience and a focus on ESG initiatives. Its goal is to improve the health and well-being of patients worldwide by delivering specialty medicines and advancing sustainable practices.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Hazelwood, Missouri

Founded

1867

Simplify Jobs

Simplify's Take

What believers are saying

  • Merger with Endo completed, forming NYSE-listed therapeutics leader by Q4 2025.
  • Reduced debt 47% to $865.6M and grew Acthar Gel sales 14.2% in 2024.
  • Sold Therakos for $925M, optimizing portfolio for specialty pharmaceuticals.

What critics are saying

  • Endo merger integration disrupts operations, overloading with $6.7B debt.
  • Therakos sale drops immunotherapy revenue, losing edge to Amgen immediately.
  • Acthar Gel's $300K pricing triggers DOJ probe and $500M fines within 18 months.

What makes Mallinckrodt unique

  • Mallinckrodt specializes in Acthar Gel for autoimmune diseases over 150 years.
  • Focuses on rare diseases and critical care therapies for underserved patients.
  • Launched Acthar Gel self-injectable to improve patient adherence and convenience.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

Relocation Assistance

Company News

PR Newswire
Nov 10th, 2025
Par Health Completes Spin-Off from Mallinckrodt, Creating an Independent Leader in Generic Pharmaceuticals and Sterile Injectables

Launches as Top 15 U.S. Generic Drug Manufacturer, Largest U.S. Producer of Active Pharmaceutical Ingredients and Premier U.S. Producer of Sterile Injectables...

Contract Pharma
Aug 6th, 2025
Mallinckrodt Names Christiana Stamoulis President and CFO

Mallinckrodt plc appointed Christiana Stamoulis as President and Chief Financial Officer, effective September 22, 2025.

Stock Titan
Aug 1st, 2025
Mallinckrodt-Endo Merger Creates Therapeutics Leader

Mallinckrodt and Endo have completed a merger to form a global therapeutics leader. The companies will combine their generics businesses and Endo's sterile injectables business, which will be spun off as an independent company by Q4 2025. The newly branded company will be listed on the New York Stock Exchange following the spin-off.

The Business Journals
Jul 25th, 2025
Mallinckrodt Reaches $7B Merger Milestone

Mallinckrodt has reached a milestone in a $7 billion merger deal.

Sharecast
Mar 13th, 2025
Mallinckrodt and Endo to merge in $6.7bn deal

Pharmaceutical firm Mallinckrodt said on Thursday that it has agreed to merge with Endo in a $6.7bn deal.

INACTIVE